The spot 14 protein inhibits growth and induces differentiation and cell death of human MCF-7 breast cancer cells

Biochemical Journal

Volumn 390, Issue 1, 2005, Pages 57-65

  Sanchez Rodriguez, Jinny ^a,b   Kaninda Tshilumbu, John P ^a   Santos, Angel ^c   Perez Castillo, Ana ^a  

^a CSIC   (Spain)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Apoptosis; Breast cancer; Lipid accumulation; MCF 7; Proliferation; Spot 14

Indexed keywords

BIOLOGICAL ORGANS; CELL CULTURE; ENZYMES; TUMORS;

BRESTS; MAMMARY GLANDS; MCF-7; SPOT 14;

TISSUE;

CYCLIN D1;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME 11Q; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; SPOT 14 GENE; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL DEATH; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLECALCIFEROL; CYCLIN D1; GENE EXPRESSION; HUMANS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN D2; PROTEINS; TIME FACTORS; TRANSCRIPTION FACTORS; TRETINOIN;

MINK CELL FOCUS-FORMING VIRUS;

EID: 23944498100     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20042080     Document Type: Article

References (43)

1. Liaw, C. W. and Towle, H. C. (1984) Characterization of a thyroid hormone-responsive gene from rat. J. Biol. Chem. 259, 7253-7260
2. Jump, D. B. and Oppenheimer, J. H. (1984) High basal expression and 3,5,3′-triiodothyronine regulation of messenger ribonucleic acid S14 in lipogenic tissues. Endocrinology 117, 2259-2266
3. Sudo, Y., Goto, Y. and Mariash, C. N. (1993) Location of a glucose-dependent response region in the rat S14 promoter. Endocrinology 133, 1221-1229
4. Kinlaw, W. B., Perez-Castillo, A. M., Fish, L. H., Mariash, C. N., Schwartz, H. L. and Oppenheimer, J. H. (1987) Interaction of dietary carbohydrate and glucagon in regulation of rat hepatic messenger ribonucleic acid S14 expression: role of circadian factors and 3′,5′-cyclic adenosine monophosphate. Mol. Endocrinol. 1, 609-613
5. Freake, H. C. and Oppenheimer, J. H. (1987) Stimulation of S14 mRNA and lipogenesis in brown fat by hypothyroidism, cold exposure, and cafeteria feeding: evidence supporting a general role for S14 in lipogenesis and lipogenesis in the maintenance of thermogenesis. Proc. Natl. Acad. Sci. U.S.A. 84, 3070-3074
6. Perez-Castillo, A., Schwartz, H. L. and Oppenheimer, J. H. (1987) Rat hepatic mRNA-S14 and lipogenic enzymes during weaning: role of S14 in lipogenesis. Am. J. Physiol. 253, E536-E542
7. Zhu, Q., Mariash, A., Margosian, M. R., Gopinath, S., Fareed, M. T., Anderson, G. W. and Mariash, C. N. (2001) Spot 14 gene deletion increases hepatic de novo lipogenesis. Endocrinology 142, 4363-4370
8. Anderson, G., Qihong, Z., Mucha, G., Salama, S., Metkowski, J. and Mariash, A. (2004) The Spot 14 related proteins regulate de novo lipogenesis and resistance to diet induced obesity. The Endocrine Society's 86th Annual Meeting, New Orleans, LA, abstract no. OR 34-2, pp. 122-123
9. Oppenheimer, J. H., Kinlaw, W. B., Wong, N. C., Schwartz, H. L. and Mariash, C. N. (1987) Regulation of gene S-14 by triiodothyronine in liver. Horm. Metab. Res. Suppl. 17, 1-5
10. Kinlaw, W. B., Tron, P. and Friedmann, A. S. (1992) Nuclear localization and hepatic zonation of rat 'spot 14' protein: immunohistochemical investigation employing anti-fusion protein antibodies. Endocrinology 131, 3120-3122
11. Kinlaw, W. B., Church, J. L., Harmon, J. and Mariash, C. N. (1995) Direct evidence for a role of the 'spot 14' protein in the regulation of lipid synthesis. J. Biol. Chem. 270, 16615-16618
12. Alo, P. L., Visca, P., Marci, A., Mangoni, A., Botti, C. and Di Tondo, U. (1996) Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer 77, 474-482
13. Milgraum, L. Z., Witters, L. A., Pasternack, G. R. and Kuhajda, F. P. (1997) Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin. Cancer Res. 3, 2115-2120
14. Joyeux, C., Rochefort, H. and Chalbos, D. (1989) Progestin increases gene transcription and messenger ribonucleic acid stability of fatty acid synthetase in breast cancer cells. Mol. Endocrinol. 3, 681-686
15. Kumar-Sinha, C., Ignatoski, K. W., Lippman, M. E., Ethier, S. P. and Chinnaiyan, A. M. (2003) Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res. 63, 132-139
16. Kuhajda, F. P., Jenner, K., Wood, F. D., Hennigar, R. A., Jacobs, L. B., Dick, J. D. and Pasternack, G. R. (1994) Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc. Natl. Acad. Sci. U.S.A. 91, 6379-6383
17. Pizer, E. S., Thupari, J., Han, W. F., Pinn, M. L., Chrest, F. J., Frehywot, G. L., Townsend, C. A. and Kuhajda, F. P. (2000) Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res. 60, 213-218
18. Sartorelli, A. C. (1985) The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach. Br. J. Cancer 52, 293-302
19. You, H., Yu, W., Sanders, B. G. and Kline, K. (2001) RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation. Cell Growth Differ. 12, 471-480
20. Byers, S., Pishvaian, M., Crockett, C., Peer, C., Tozeren, A., Sporn, M., Anzano, M. and Lechleider, R. (1996) Retinoids increase cell-cell adhesion strength, beta-catenin protein stability, and localization to the cell membrane in a breast cancer cell line: a role for serine kinase activity. Endocrinology 137, 3265-3273
21. Lazzaro, G., Agadir, A., Qing, W., Poria, M., Mehta, R. R., Moriarty, R. M., Das Gupta, T. K., Zhang, X. K. and Mehta, R. G. (2000) Induction of differentiation by 1alpha-hydroxyvitamin D(5) in T47D human breast cancer cells and its interaction with vitamin D receptors. Eur. J. Cancer 36, 780-786
22. Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S. and Spiegelman, B. M. (1998) Terminal differentiation of human breast cancer through PPAR gamma. Mol. Cell 1, 465-470
23. Pignatelli, M., Cortes-Canteli, M., Lai, C., Santos, A. and Perez-Castillo, A. (2001) The peroxisome proliferator-activated receptor gamma is an inhibitor of ErbBs activity in human breast cancer cells. J. Cell Sci. 114, 4117-4126
24. Munster, P. N., Srethapakdi, M., Moasser, M. M. and Rosen, N. (2001) Inhibition of heat shock protein 90 function by ansamycins causes the morphological and functional differentiation of breast cancer cells. Cancer Res. 61, 2945-2952
25. Moncur, J. T., Park, J. P., Memoli, V. A., Mohandas, T. K. and Kinlaw, W. B. (1998) The 'Spot 14' gene resides on the telomeric end of the 11q13 amplicon and is expressed in lipogenic breast cancers: implications for control of tumor metabolism. Proc. Natl. Acad. Sci. U.S.A. 95, 6989-6994
26. Perusse, L., Chagnon, Y. C., Dionne, F. T. and Bouchard, C. (1997) The human obesity gene map: the 1996 update. Obes. Res. 5, 49-61
27. Schuuring, E., Verhoeven, E., van Tinteren, H., Peterse, J. L., Nunnink, B., Thunnissen, F. B., Devilee, P., Cornelisse, C. J., van de Vijver, M. J., Mooi, W. J. et al. (1992) Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res. 52, 5229-5234
28. Champeme, M. H., Bieche, I., Lizard, S. and Lidereau, R. (1995) 11q13 amplification in local recurrence of human primary breast cancer. Genes Chromosomes Cancer 12, 128-133
29. Heemers, H., Vanderhoydonc, F., Heyns, W., Verhoeven, G. and Swinnen, J. V. (2000) Progestins and androgens increase expression of Spot 14 in T47-D breast tumor cells. Biochem. Biophys. Res. Commun. 269, 209-212
30. Martel, P., Nunlist, E., Bingham, C. and Kinlaw, W. (2004) Sterol response element-binding protein 1c (SREBP-1c) is required for the induction of s14 and fatty acid synthase (FAS) gene expression by progestin in human breast cancer cells, and is a major determinant of the lipogenic tumor phenotype. The Endocrine Society's 86th Annual Meeting, New Orleans, LA, abstract no. P1-277, p. 221
31. Herber, B., Truss, M., Beato, M. and Muller, R. (1994) Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9,1295-1304
32. Greenspan, P., Mayer, E. P. and Fowler, S. D. (1985) Nile red: a selective fluorescent stain for intracellular lipid droplets. J. Cell Biol. 100, 965-973
33. Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A. and Schmidt, E. V. (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (London) 369, 669-671
34. Cohen, L. A., Amin, S., Marks, P. A., Rifkind, R. A., Desai, D. and Richon, V. M. (1999) Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA). Anticancer Res. 19, 4999-5005
35. Martinez, L. A., Chen, Y., Pavone, A., Fischer, S. M. and Conti, C. J. (2000) Deregulated expression of cyclin D1 overrides antimitogenic signals. Oncogene 19, 315-322
36. Zwijsen, R. M., Klompmaker, R., Wientjens, E. B., Kristel, P. M., van der Burg, B. and Michalides, R. J. (1996) Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol. Cell. Biol. 16, 2554-2560
37. Bartkova, J., Lukas, J., Muller, H., Lutzhoft, D., Strauss, M. and Bartek, J. (1994) Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57, 353-361
38. Sweeney, C., Fambrough, D., Huard, C., Diamonti, A. J., Lander, E. S., Cantley, L. C. and Carraway, III, K. L. (2001) Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors. J. Biol. Chem. 276, 22685-22698
39. Aranda, A. and Pascual, A. (2001) Nuclear hormone receptors and gene expression. Physiol. Rev. 81, 1269-1304
40. Altucci, L. and Gronemeyer, H. (2001) Nuclear receptors in cell life and death. Trends Endocrinol. Metab. 12, 460-468
41. Freemantle, S. J., Spinella, M. J. and Dmitrovsky, E. (2003) Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22, 7305-7315
42. Koeffler, H. P. (2003) Peroxisome proliferator-activated receptor gamma and cancers. Clin. Cancer Res. 9, 1-9
43. Lin, R. and White, J. H. (2004) The pleiotropic actions of vitamin D. Bioessays 26, 21-28